Keyword Connections

biologics

Journals

7

1 Frontiers in medicine

2 Future medicinal chemistry

3 journal of autoimmunity

4 allergy

5 expert opinion on biological therapy

6 reumatismo

7 Journal of health economics and outcomes research

Research Groups

0

No Research Group Connected

Bibliographies

29

1 Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide.

2 The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia.

3 The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.

4 The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica.

5 gp96 peptide antagonist gp96-ii confers therapeutic effects in murine intestinal inflammation

6 spotlight on tocilizumab and its potential in the treatment of systemic sclerosis

7 update and new approaches in the treatment of castleman disease

8 applications of yeast synthetic biology geared towards the production of biopharmaceuticals

9 Behçet uveitis: Current practice and future perspectives.

10 Validation of a Model Estimating the Budget Impact of Video Capsule Endoscopy for Surveillance of Crohn's Disease in an Italian Center.

11 Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

12 Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.

13 [SWITCHING BIOLOGICS LED TO GOOD CONTROL IN SEVERE CHILDHOOD ASTHMA: A CASE REPORT].

14 New paradigm in asthma management: switching between biologics!

15 Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications with the US Food and Drug Administration

16 Use of FDA-Approved Medications: Biologics for Psoriatic Arthritis in Patients at an Urban Outpatient Rheumatology Clinic.

17 FDA Regulatory Concerns for Wound Healing Biologics

18 2019-2020 NFL and NFL Physician Society Orthobiologics Consensus Statement.

19 Reply to: "Biologics for psoriasis during COVID-19 outbreak".

20 High-Density Lipoprotein Nanobiologics for Precision Medicine.

21 [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]

22 funding the new biologics – public policy issues in drug formulary decision making

23 gene therapy for the treatment of parkinson’s disease: the nature of the biologics expands the future indications

24 subacute thyroiditis in psoriasis patients treated with biologics targeting tumor necrosis factor‐α and interleukin‐17a, a report of two cases

25 postmarketing commitments for novel drugs and biologics approved by the us food and drug administration: a cross-sectional analysis

26 biosimilars: company strategies to capture value from the biologics market

27 plant-made biologics

28 regulated cell death as a therapeutic target for novel antifungal peptides and biologics

29 an overall comparison of small molecules and large biologics in adme testing